Targeted proteomics improves cardiovascular risk prediction in secondary prevention
Nick S. Nurmohamed(Amsterdam Neuroscience), Erik S.G. Stroes(Amsterdam UMC Location University of Amsterdam), Michiel J. Bom(Amsterdam UMC Location Vrije Universiteit Amsterdam), João Pereira(Amsterdam University Medical Centers), Wolfgang Köenig(Brigham and Women's Hospital), Paul Knaapen(Amsterdam University Medical Centers), Renate M. Hoogeveen(Amsterdam University Medical Centers), Dominique P.V. de Kleijn(National University of Singapore), Imo E. Hoefer(Utrecht University), Nathalie Timmerman(Utrecht University), Frank L.J. Visseren, Jeffrey Kroon(University of Amsterdam), Evgeni Levin(Amsterdam University Medical Centers), Jordan M Kraaijenhof(Amsterdam University Medical Centers), Alberico L. Catapano(University of Milan), Farahnaz Waissi(Utrecht University)
Cited by 133
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2021|6.1k